Focus on Schizophrenia Research

Schizophrenia

Our Areas of Interest for Collaboration


Novel Therapies in Phase 2b or Later for Symptomatic Treatment of the Underlying Symptoms of Schizophrenia with Special Emphasis on Treatment of Cognitive Impairment and Negative Symptoms.	Biomarkers and Integrated Solutions
	Prognostic biomarkers to identify patients at risk for disease Predictive biomarkers for treatment response Integrated solutions for patient diagnosis or treatment assessment Cognitive tests for measuring disease progression

Neuroscience

Nerve fibers